top of page
On the Scales

TIRZEPATIDE (GLP-1 & GIP agonist)

Tirzepatide is a weight loss drug that has had extensive clinical studies showing its safety and efficacy. It is an injectable medication that increases your satiety and reduces food intake.

Tirzepatide is a dual agonist targeting both the glucagon-like peptide-1 receptor (GLP-1) and the glucose-dependent insulinotropic polypeptide (GIP) receptor. This dual action improves appetite suppression and thus improves weight loss.  


Additionally, Tirzepatide also influences metabolism by optimizing energy utilization, shifting the body's preference from glucose to fat as an energy source. By enhancing insulin sensitivity and promoting fat burning, Tirzepatide aids in weight loss efforts and lessens the need to emotionally eat.

​

As of March 15th, 2025, Tirzepatide is only available when compounded with a second ingredient and for the needs of the patient.  Our pharmacy compounds Tirzepatide with B6.


Tirzepatide is a once weekly injection that you administer yourself at home. The benefits help reduce hunger pangs and helps you lose weight faster when combined with a low-calorie diet and exercise.

​

Our affiliate pharmacies are committed to providing high-quality products and exceptional care in accordance with all applicable laws.

PATIENT TESTIMONIALS

"I absolutely love it! I have no cravings and I am not hungry. I am losing weight and it has never been easier in my life! Completely sold"

--Melanie E.

Get started with as little as 

$199/mo

We deliver effective weight loss medication directly to your door so you have the privacy and convenience to start your weight loss journey.

My Easy Weight Loss Profile Photo (2).png

MY EASY WEIGHT LOSS

The recognized brand name medications approved by the FDA, Zepbound™ & Mounjaro®, are manufactured by Eli Lilly and Company™. Ozempic® & Wegovy® are manufactured by Novo Nordisk™. We do NOT manufacture these medications and have no affiliation with Eli Lilly and Company™ or Novo Nordisk™.

PROVEN WEIGHT LOSS

bottom of page